Cardinal Health, Inc (NYSE: CAH) on Tuesday, plunged -0.63% from the previous trading day, before settling in for the closing price of $116.55. Within the past 52 weeks, CAH’s price has moved between $93.17 and $126.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 9.33%. The company achieved an average annual earnings per share of 3.94%. With a float of $241.34 million, this company’s outstanding shares have now reached $242.00 million.
Considering the fact that the conglomerate employs 48900 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 3.31%, operating margin of 0.97%, and the pretax margin is 0.79%.
Cardinal Health, Inc (CAH) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Distribution industry stocks is more important than anything else. The insider ownership of Cardinal Health, Inc is 0.28%, while institutional ownership is 88.83%. The most recent insider transaction that took place on Nov 14 ’24, was worth 432,919. In this transaction Chief Accounting Officer of this company sold 3,504 shares at a rate of $123.55, taking the stock ownership to the 8,752 shares. Before that another transaction happened on Aug 21 ’24, when Company’s Chief Legal/Compliance Officer sold 16,573 for $109.39, making the entire transaction worth $1,812,920. This insider now owns 75,971 shares in total.
Cardinal Health, Inc (CAH) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 3.94% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.00% during the next five years compared to -5.30% drop over the previous five years of trading.
Cardinal Health, Inc (NYSE: CAH) Trading Performance Indicators
Cardinal Health, Inc (CAH) is currently performing well based on its current performance indicators. A quick ratio of 0.50 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.12. Likewise, its price to free cash flow for the trailing twelve months is 26.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.15, a number that is poised to hit 1.76 in the next quarter and is forecasted to reach 8.68 in one year’s time.
Technical Analysis of Cardinal Health, Inc (CAH)
Compared to the last year’s volume of 2.1 million, its volume of 2.05 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 9.54%. Additionally, its Average True Range was 2.61.
During the past 100 days, Cardinal Health, Inc’s (CAH) raw stochastic average was set at 65.51%, which indicates a significant increase from 10.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.40% in the past 14 days, which was lower than the 23.31% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $117.08, while its 200-day Moving Average is $107.70. Nevertheless, the first resistance level for the watch stands at $116.73 in the near term. At $117.63, the stock is likely to face the second major resistance level. The third major resistance level sits at $118.70. If the price goes on to break the first support level at $114.76, it is likely to go to the next support level at $113.69. Now, if the price goes above the second support level, the third support stands at $112.79.
Cardinal Health, Inc (NYSE: CAH) Key Stats
Market capitalization of the company is 28.03 billion based on 242,010K outstanding shares. Right now, sales total 226,827 M and income totals 852,000 K. The company made 52,277 M in profit during its latest quarter, and 416,000 K in sales during its previous quarter.
